HTGM Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (14 birž. 2023 @ 23:00):

Stats
Šios dienos apimtis	725 429
Vidutinė apimtis	253 915
Rinkos kapitalizacija	1.06M
EPS	$0 ( 2024-03-28 )
Kita pelno data	( $0 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0281
ATR14	$0.314 (65.42%)

Insider Trading

Date	Person	Action	Amount	type
2023-06-08	Barat Stephen	Sell	888	Common Stock
2023-03-31	Barat Stephen	Sell	52	Common Stock
2023-02-02	Barat Stephen	Sell	0	Common Stock
2023-02-02	Barat Stephen	Sell	4 166	Stock Option (right to buy)
2023-02-02	Barat Stephen	Sell	2 083	Stock Option (right to buy)

INSIDER POWER
93.71
Last 98 transactions
Buy: 3 245 171 \| Sell: 16 674

Tūris Koreliacija

Ilgas: 0.10 (neutral)

Trumpas: -0.53 (weak negative)

Signal:(18.674) Neutral

HTG Molecular Diagnostics Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

HTG Molecular Diagnostics Koreliacija - Valiuta/Žaliavos

0.64
( weak )

0.73
( moderate )

0.00
( neutral )

0.75
( moderate )

-0.12
( neutral )

-0.75
( moderate negative )

HTG Molecular Diagnostics Finansinės ataskaitos

Annual	2022
Pajamos:	$6.37M
Bruto pelnas:	$1.79M (28.18 %)
EPS:	$-24.28

FY	2022
Pajamos:	$6.37M
Bruto pelnas:	$1.79M (28.18 %)
EPS:	$-24.28

FY	2021
Pajamos:	$8.91M
Bruto pelnas:	$716 868 (8.05 %)
EPS:	$-0.206

FY	2020
Pajamos:	$8.55M
Bruto pelnas:	$4.56M (53.31 %)
EPS:	$-0.376

Financial Reports:

No articles found.

HTG Molecular Diagnostics

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq DLBCL cell of origin assay; HTG EdgeSeq Oncology Biomarker Panel; HTG EdgeSeq ALKPlus assay EU; HTG EdgeSeq Pan B-Cell Lymphoma Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. HTG Molecular Diagnostics, Inc. has a governing agreement with QIAGEN Manchester Limited. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.